|Message:||Recipients' Email:||Type address separated by commas|
|Your Email:||Enter the characters shown in the image.|
|Send me a copy:|
For the first time, all chronic therapy drugs grew only in single digits during May.
According to analysts, a slew of factors were responsible for the slowdown — a weak season resulting in lower offtake (mainly acute therapy medicines), slump in product launches in the chronic segment pulling ...
Read the full text business-standard